Hence, we assessed the expression profile of genes involved in these signaling pathways to clarify the contribution of EGFR inhibition into the mechanism of the anti-cancer activity of the compounds tested in CAL-27 and SCC-25 cells. This evidence concerns the gene EGFR and cancer.